Rs 150 per dose is not sustainable in long run: Bharat Biotech on Centre's Covaxin price

The company said, as directed by the Government of India, less than 10 per cent of the total production of Covaxin to date has been supplied to private hospitals.

published on : 15th June 2021

Recruitment for clinical trial of Covaxin in 6-12 age group to start at AIIMS from June 15

The trial is to be conducted in three parts -- 175 volunteers each in the groups aged 12-18, 6-12 and 2-6 years.

published on : 14th June 2021

Short supply: Covaxin first shot stops in Uttarakhand

It has been learnt that the state has not received adequate supply from the manufacturers.

published on : 13th June 2021

Covaxin supply issues in Delhi addressed: HC

The court disposed of the three pleas filed by persons who were finding it difficult to get the second dose of Covaxin after getting the first jab as they have been fully vaccinated now.

published on : 12th June 2021

Covaxin's emergency nod push in US fails

No vaccine manufactured or developed from India has ever received emergency use authorisation or full licensure from USFDA.

published on : 12th June 2021

US FDA rejects emergency authorisation for Covaxin, 'recommends' to take full approval route

Ocugen is in discussions with the FDA to understand the additional information required to support a BLA submission.

published on : 11th June 2021

TN receives 85k doses of Covaxin

Health Secy says State needs at least 2 crore doses a month to speed up vaccination drive

published on : 11th June 2021

Final phase 3 trials data on Covaxin in July, says Bharat Biotech; experts question delay

"It is unusual to have such a delay, particularly when the second analysis was so close to the sample size of 130 symptomatic cases," said a top virologist who did not wish to be named.

published on : 9th June 2021

Covaxin stock for 45-plus age group almost over: Atishi

Out of Delhi's total 5.50 lakh vaccine stock on Tuesday available for people above 45 years, 5.44 lakh were Covishield and 8,000 Covaxin, the MLA from Kalkaji said.

published on : 9th June 2021

Punjab to administer Covishield 2nd dose after 28 days to those travelling abroad: Minister

The Union Ministry of Health and Family Welfare has issued recommendations to provide vaccines to such people who have completed 28 days of their first dose, said Sidhu.

published on : 8th June 2021

Government sets maximum price of vaccines for private hospitals: Covishield Rs 780 a dose, Covaxin Rs 1410

In a letter to all states and union territories on Tuesday, the Health Ministry suggested that appropriate strict action be taken against private vaccination centres for overcharging.

published on : 8th June 2021

Covaxin less effective against B.1.617.2 variant responsible for second wave: Study

Researchers associated with ICMR-National Institute of Virology and Bharat Biotech  studied neutralization of the parental B.1 virus and variants of concern- B.1.351 and B.1.617.

published on : 8th June 2021

Another 44 crore Covid vaccines ordered, 2.16 billion doses by December-end is the promise 

With the latest purchase orders, the government has secured 74 crore coronavirus vaccine doses for the country from August onwards, announced V K Paul.

published on : 8th June 2021

Ocugen pays USD 15 million upfront to Bharat Biotech for Covaxin rights in Canada

Ocugen in a regulatory filing said it has agreed to pay another USD 10 million to Bharat Biotech within a month from the commercial launch of Covaxin in the North American country.

published on : 8th June 2021

Fresh Covaxin only for second dose for 18-44 age group in Delhi

Issuing the daily vaccination bulletin on Monday, AAP MLA Atishi said for the 18-44 segment, Delhi has a stock of 40,840 vaccines, out of which 40,300 are Covaxin doses.

published on : 8th June 2021
1 2 3 4 5 6 >